>
>
Clinical Risk Grouping Solution Market – By Component (Software {Private & Public Cloud}, Service), Application (Population Health, Chronic Disease Management, Clinical Decision Support), End-use (ASC, Hospital & Clinic), Global Forecast (2024 – 2032)
Download Free PDF

Clinical Risk Grouping Solution Market
Get a free sample of this reportGet a free sample of this report Clinical Risk Grouping Solution Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 14
Tables & Figures: 213
Countries covered: 22
Pages: 128
Download Free PDF
Clinical Risk Grouping Solution Market Size
Clinical Risk Grouping Solution Market size was valued at USD 673.4 million in 2023 growing at a CAGR of 11.5% between 2024 and 2032. Clinical risk grouping solutions help in identifying high-risk patients and managing the care more efficiently. Therefore, one of the primary drivers is the increasing healthcare cost, as healthcare costs continue to rise, there is a greater need for solutions that can effectively manage and mitigate the expenses of treatment.
Additionally, the rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer increases the need for effective population health management solutions. For instance, as per the report published by World Health Organization it has been reported that noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).
Thus, the rapid increase in the prevalence of chronic disease globally is the major factor that is expanding the demand for clinical risk grouping solution for better risk stratification and to manage patient populations and improve healthcare outcomes, thereby driving the market growth. A clinical risk grouping solution (CRGS) is a sophisticated tool or system used in healthcare to categorize patients based on their clinical risk. The main purpose of CRGS is to predict and manage healthcare outcomes, optimize resource utilization, and improve patient care by identifying individuals at varying levels of health risk.
Clinical Risk Grouping Solution Market Trends
The increase in adoption of electronic health records (EHR) system at healthcare facilities such as hospitals, clinics, and ambulatory care centers, has been a key driver for clinical risk grouping solution industry. Also, innovations in data analytics, artificial intelligence, and machine learning enhance the capabilities of clinical risk grouping solutions such as EHRs software. These advancements enable more accurate risk prediction and better patient management.
Clinical Risk Grouping Solution Market Analysis
Based on the component, the market is classified into software and services. The software segment dominated the market with revenue of USD 526.1 million in 2023.
Based on the application, the global clinical risk grouping solution market is classified into population health management, chronic disease management, clinical decision support, fraud detection and prevention, and other applications. The population health management segment dominated the market with market share of 33.2% in 2023.
Based on end-use, the clinical risk grouping solution market is classified into hospitals & clinics, ambulatory surgical centers, long term care centers, and other end-users. The hospitals & clinics segment is expected to exhibit 11.8% CAGR between 2024 - 2032.
In 2023, North America secured a substantial market share of 45.2% in the global clinical risk grouping solution market and is expected to dominate throughout the forecast period.
Germany to experience the highest growth rate in the Europe market.
The Asia Pacific clinical risk grouping solution market is expected to grow with a significant CAGR of 11.9% during the forecast period.
Clinical Risk Grouping Solution Market Share
The clinical risk grouping solution industry is characterized by intense competition among key players aiming to expand their market presence. Leading companies are focusing on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market position. These efforts are aimed at enhancing their service offerings, expanding their geographic reach, and investing in advanced technologies. The market also witnesses the entry of new players, intensifying the competitive landscape further.
Clinical Risk Grouping Solution Market Companies
Prominent players operating in the clinical risk grouping solution industry are as mentioned below:
Clinical Risk Grouping Solution Industry News:
The clinical risk grouping solution market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Component
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: